NCT07076082View on ClinicalTrials.gov

Vascular Trial Associated Registry Pilot

PHASE4RecruitingINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

October 15, 2025

Primary Completion Date

October 30, 2027

Study Completion Date

October 30, 2028

Conditions
Peripheral Arterial Disease
Interventions
DRUG

Clopidogrel (Plavix) Pharmacogenetic Test Reagents

Dual antiplatelet therapy (DAPT), defined as the use of Clopidogrel (75 mg/day) (clopidogrel) and aspirin (81 mg or more/day). Single antiplatelet therapy (SAPT), defined as the use of aspirin (81 mg or more/day).

Trial Locations (2)

49503

RECRUITING

Corewell Health, Grand Rapids

48202-2608

NOT_YET_RECRUITING

Henry Ford Hospital, Detroit

All Listed Sponsors
collaborator

Henry Ford Hospital

OTHER

lead

Spectrum Health Hospitals

OTHER